GeoVax
GA - SmyrnaBiotechnology
Focus: GeoVax is a vaccine-focused biotech company headquartered in Smyrna, Georgia, developing immunotherapies for infectious diseases and oncology. The company operates at pre-revenue stage with early-stage pipeline programs across COVID-19, HIV, and cancer indications.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Open Jobs
0
About GeoVax
AI assessmentNot HiringNo open roles listed right now. Follow GeoVax to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GEO-D02 DNA
HIV InfectionsClinical Trials (1)
NCT04041674Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants
Phase 1Help build intelligence for GeoVax
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.